Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Non-Interventional Study To Investigate The Efficacy And Safety Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice.

NCT00858208 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00858208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00858208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Non-Interventional Study To Investigate The Efficacy And Safety Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice.
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
March 31, 2008
Completion date
April 30, 2011
Enrollment
86 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular age-related macular degeneration